Beneficial Effects of Sulforaphane Treatment in Alzheimer's Disease May Be Mediated through Reduced HDAC1/3 and Increased P75NTR Expression
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beneficial Effects of Sulforaphane Treatment in Alzheimer's Disease May Be Mediated through Reduced HDAC1/3 and Increased P75NTR Expression
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-05-01
DOI
10.3389/fnagi.2017.00121
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amyloid-β Peptides Stimulate the Expression of the p75NTR Neurotrophin Receptor in SHSY5Y Human Neuroblastoma Cells and AD Transgenic Mice
- (2017) Balu Chakravarthy et al. JOURNAL OF ALZHEIMERS DISEASE
- Sulforaphane Prevents Neuronal Apoptosis and Memory Impairment in Diabetic Rats
- (2016) Gengyin Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Sulforaphane promotes immune responses in a WEHI-3-induced leukemia mouse model through enhanced phagocytosis of macrophages and natural killer cell activities in vivo
- (2016) YUNG-LUEN SHIH et al. Molecular Medicine Reports
- Sulforaphane epigenetically enhances neuronal BDNF expression and TrkB signaling pathways
- (2016) Jisung Kim et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Increased Acetylation of Histone H4 at Lysine 12 (H4K12) in Monocytes of Transgenic Alzheimer’s Mice and in Human Patients
- (2015) Barbara Plagg et al. Current Alzheimer Research
- p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer’s disease
- (2015) X-Q Yao et al. MOLECULAR PSYCHIATRY
- Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases
- (2015) Miguel Chin-Chan et al. Frontiers in Cellular Neuroscience
- Sulforaphane Ameliorates Neurobehavioral Deficits and Protects the Brain From Amyloid β Deposits and Peroxidation in Mice With Alzheimer-Like Lesions
- (2014) Rui Zhang et al. American Journal of Alzheimers Disease and Other Dementias
- Requirement and Epigenetics Reprogramming of Nrf2 in Suppression of Tumor Promoter TPA-Induced Mouse Skin Cell Transformation by Sulforaphane
- (2014) Z.-Y. Su et al. Cancer Prevention Research
- Neuroprotective Effects of Sulforaphane on Cholinergic Neurons in Mice with Alzheimer’s Disease-Like Lesions
- (2014) Rui Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sulforaphane protects against ethanol-induced oxidative stress and apoptosis in neural crest cells by the induction of Nrf2-mediated antioxidant response
- (2013) X Chen et al. BRITISH JOURNAL OF PHARMACOLOGY
- A new ultra-rapid UHPLC/MS/MS method for assessing glucoraphanin and sulforaphane bioavailability in human urine
- (2013) Raul Dominguez-Perles et al. FOOD CHEMISTRY
- Attenuation ofβ-Amyloid-Induced Oxidative Cell Death by Sulforaphane via Activation of NF-E2-Related Factor 2
- (2013) Chan Lee et al. Oxidative Medicine and Cellular Longevity
- Histone deacetylase inhibitors are neuroprotective and preserve NGF-mediated cell survival following traumatic brain injury
- (2013) J. Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer’s disease
- (2012) Michael P. Walker et al. AGE
- The relationship between subcortical tau pathology and Alzheimer's disease
- (2012) Johannes Attems et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Neuroprotective Effects of Sulforaphane after Contusive Spinal Cord Injury
- (2012) Andrea L. Benedict et al. JOURNAL OF NEUROTRAUMA
- Roles of p75NTR in the pathogenesis of Alzheimer's disease: A novel therapeutic target
- (2011) Fan Zeng et al. BIOCHEMICAL PHARMACOLOGY
- p75NTR Regulates A Deposition by Increasing A Production But Inhibiting A Aggregation with Its Extracellular Domain
- (2011) Y.-J. Wang et al. JOURNAL OF NEUROSCIENCE
- Targeting HDACs: A Promising Therapy for Alzheimer's Disease
- (2011) Ke Xu et al. Oxidative Medicine and Cellular Longevity
- SAHA Decreases HDAC 2 and 4 Levels In Vivo and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease
- (2011) Michal Mielcarek et al. PLoS One
- A SP1/MIZ1/MYCN Repression Complex Recruits HDAC1 at theTRKAandp75NTRPromoters and Affects Neuroblastoma Malignancy by Inhibiting the Cell Response to NGF
- (2010) Nunzio Iraci et al. CANCER RESEARCH
- Romidepsin (FK228/depsipeptide) controls growth and induces apoptosis in neuroblastoma tumor cells
- (2010) Jyoti Panicker et al. CELL CYCLE
- Protection against amyloid beta cytotoxicity by sulforaphane: Role of the proteasome
- (2009) Hyun-Min Park et al. ARCHIVES OF PHARMACAL RESEARCH
- Sulforaphane suppresses LPS-induced inflammation in primary rat microglia
- (2009) Lars-Ove Brandenburg et al. INFLAMMATION RESEARCH
- Sulforaphane improves cognitive function administered following traumatic brain injury
- (2009) Pramod K. Dash et al. NEUROSCIENCE LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now